Recruiting Clinical Trials

Displaying 1 - 10 of 191 result(s)
Study Title Condition Phase Location
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
  • Bronchiectasis
  • Phase 2
  • Country: 
    China
  • Country: 
    Germany
  • Country: 
    United Kingdom
Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.
  • Non Alcoholic Steatohepatitis (NASH)
  • Phase 2
  • Country: 
    United States
  • Country: 
    Belgium
  • Country: 
    Brazil
  • Country: 
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC
  • Prostatic Neoplasms
  • Phase 3
  • Country: 
    France
  • Country: 
    Spain
Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • Phase 3
  • Country: 
    Latvia
Secukinumab Open Label Roll-over Extension Protocol
  • Autoimmunity, Inflammation
  • Phase 4
  • Country: 
    United States
  • Country: 
    Bulgaria
  • Country: 
    Czech Republic
  • Country: 
177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
  • Prostatic Neoplasms
  • Phase 3
  • Country: 
    United States
  • Country: 
    Spain
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Phase 3
  • Country: 
    Austria
  • Country: 
    Belgium
  • Country: 
    China
  • Country: 
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
  • Lupus Nephritis
  • Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Brazil
  • Country: 
Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis
  • Osteoarthritis
  • Phase 2
  • Country: 
    Australia
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
  • Systemic Lupus Erythematosus (SLE)
  • Phase 2
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
    China
  • Country: